Evidence map›Paper›PMID 21250718›Full record

ArticleThe Journal of organic chemistry2011

Synthesis-guided structure revision of the sarcodonin, sarcoviolin, and hydnellin natural product family.

David W Lin, Takeshi Masuda, Moritz B Biskup, Jonathan D Nelson, Phil S Baran

Abstract read
In one paragraph

Article in The Journal of organic chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 57 citations in OpenAlex.

  1. TheMolecules (Basel, Switzerland) · 2026
    Article
  2. ACS omega · 2023
    Article
  3. A Ring Expansion Approach ToTetrahedron letters · 2022
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

David W LinDepartment of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Takeshi Masuda
Moritz B Biskup
Jonathan D Nelson
Phil S Baran
Scripps Research Institute · US

Funding

Total Synthesis of Anti-Cancer Natural ProductsR01CA134785 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI BARAN, PHIL S · 2009 to 2010
$1.3M
NCI NIH HHS CA134785NCI NIH HHS R01 CA134785
6 · The paper itself

Abstract

A sweeping structural revision of the sarcodonin natural product family (published structures 1a-13a) is proposed after extensive studies aimed at their chemical synthesis. Key features of revised structure 1b include replacement of the N,N-dioxide moiety with an oxime, ring-opening of the central diketopiperazine, and transposition of the terphenyl wing from the 1β-2β position of 1a to the 2β-3β position of 1b. This structure revision arose from the serendipitous synthesis of a benzodioxane aminal (44) whose structure was unambiguously determined by X-ray crystallography and whose spectral properties bore considerable resemblance to the published data for the sarcodonins. A versatile new method for O-arylation of hydroxamic acids is also reported herein, as well as a manganese(III)-mediated α-oxidation of hydroxamic acids to aminals.

Indexed as

Biological ProductsCrystallography, X-RayMolecular StructureOxidation-ReductionStereoisomerismTerpenesBiological Productshydnellinsarcodonin MsarcoviolinTerpenes

Identifiers

PMID21250718
PMCPMC3089814
OpenAlexW1973551138

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.